• Blueprint Medicines average return on investment for 2024 was -36.25, a 67.23% decline from 2023.
• Blueprint Medicines average return on investment for 2023 was -110.61, a 63.26% decline from 2022.
• Blueprint Medicines average return on investment for 2022 was -301.09, a 9.92% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.